Biliary Tract Cancer Clinical Trials in Baltimore, Maryland
4 recruitingBaltimore, Maryland
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Biliary Tract Cancer
AstraZeneca1,100 enrolled168 locationsNCT07221253
Recruiting
Phase 2
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
Biliary Tract CancerHepatocellular Carcinoma
Replimune Inc.60 enrolled11 locationsNCT05733598
Recruiting
Phase 1
Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
Biliary Tract CancerCholangiocarcinoma
University of Maryland, Baltimore15 enrolled2 locationsNCT06546969
Recruiting
Phase 1
Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)
Biliary Tract Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins25 enrolled1 locationNCT06564623